Corrected data : block b1"product problem" was updated to "product problem/ adverse event" due to the lack of information, the worst case scenario was considered.Block b2 was completed as required.(4111) several attempts to contact the customer was performed by the medical department.No response could be obtained.(4112/213) the case was reviewed by the corporate medical department whose assessment is below: "the complaint received states that a hemagard 14x7 bifurcated graft was implanted in a patient.It appears that the hemagard graft is a substitute for their typically used graft, however the brand of graft is unknown at this time.The customer states that the hemagard graft is soft, flimsy and kinks easily, causing bleeding after repeated attempts to implant.No other information is known at this time.Retention product from the same lot, coated on the same day was visually inspected and underwent water permeability testing and revealed that the product is within specifications.A request for additional details of the procedure has been sent back to the customer, and these comments and summary will be updated when they are received.Attempts to request further information on this complaint were made on dec 14, 2022; dec 15, 2022; dec 22, 2022; and jan 5, 2023.There was no response.Due to the lack of information available we were unable to arrive at a conclusion.Should additional information be obtained in the future, this medical assessment will be updated to reflect those findings." (4315) no conclusion can be drawn on the exact origin of the adverse event since the product remained implanted.However, the conducted investigation and testing performed suggest that the product was not defective at the time of manufacturing.
|